Get the Stockscreener App
31.50
3.39%
-1.21
Structure Therapeutics Inc Adr Stock (GPCR) Forecast
The Structure Therapeutics Inc Adr (GPCR) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $70.97, representing a +125.30% increase from the current price of $31.50. The highest analyst price target is $89.54, and the lowest is $52.40.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month GPCR Price Target
Average 73.86
(+134.47% Upside)
Is Structure Therapeutics Inc Adr (GPCR) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 33.93 | Neutral |
| STOCH(9,6) | 26.04 | Neutral |
| STOCHRSI(14) | 15.36 | Buy |
| MACD(12,26) | -1.7224 | Sell |
| ADX(14) | 19.68 | Neutral |
| William %R | -77.63 | Neutral |
| CCI(14) | -97.10 | Neutral |
Buy: 1
Sell: 1
Neutral: 5
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
35.15
Sell
|
34.62
Sell
|
| MA20 |
37.07
Sell
|
36.21
Sell
|
| MA50 |
38.99
Sell
|
37.87
Sell
|
| MA100 |
38.52
Sell
|
38.79
Sell
|
| MA200 |
39.80
Sell
|
40.14
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, GPCR could be considered a Strong Sell, with 17 technical analysis indicators signaling 1 Buy signals, 11 signaling Sell signals and 5 Neutral signals. This might not be a good time to consider opening new positions on GPCR, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 33.93 indicates that GPCR is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 26.04 indicates that GPCR is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 15.36 indicates that GPCR is oversold. This suggests that GPCR price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 19.68 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -97.1 indicates that GPCR is still oversold but not to an extreme extent.
Long-term GPCR price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Structure Therapeutics Inc Adr financial reports and earnings history, Structure Therapeutics Inc Adr (GPCR) stock could reach $134.10 by 2030, $244.59 by 2040 and $534.98 by 2050. See the projected annual prices until 2050 of the Structure Therapeutics Inc Adr stock below:
- Structure Therapeutics Inc Adr (GPCR) is expected to reach an average price of $211.41 in 2035, with a high prediction of $212.39 and a low estimate of $194.81. This indicates an $571.14% rise from the last recorded price of $31.50.
- Structure Therapeutics Inc Adr (GPCR) stock is projected to chart a bullish course in 2040, with an average price target of $243.56, representing an $673.21% surge from its current level. The forecast ranges from a conservative $234.92 to a sky-high $244.59.
- Our analysts predict Structure Therapeutics Inc Adr (GPCR) to jump 1,376% by 2045, soaring from $449.53 to an average price of $464.98, potentially reaching $466.97. While $449.53 is the low estimate, the potential upside is significant.
- Structure Therapeutics Inc Adr (GPCR) stock is expected to climb by 2050, reaching an average of $533.43, a $1,593% jump from its current level. However, a wide range of estimates exists, with high and low targets of $534.98 and $519.58, respectively, highlighting the market's uncertainty.
Structure Therapeutics Inc Adr Stock (GPCR) Year by Year Forecast
Structure Therapeutics Inc Adr Stock (GPCR) Price Forecast for 2024
Our forecast for GPCR stock price in 2024 now indicates an average price target of $61.59 with a high forecast of $89.54 and a low forecast of $33.65. The average prediction reflects an increase of +95.54% from the last recorded price of $31.50.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| December, 2024 | $86.76 | $52.40 | $89.54 | +175.42% |
Structure Therapeutics Inc Adr Stock (GPCR) Price Forecast for 2025
Structure Therapeutics Inc Adr Stock (GPCR) is expected to reach an average price of $73.86 in 2025, with a high prediction of $97.39 and a low estimate of $50.32. This indicates an +134.47% rise from the last recorded price of $31.50.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $77.41 | $74.90 | $97.39 | +145.76% |
| February, 2025 | $82.78 | $64.96 | $83.26 | +162.80% |
| March, 2025 | $64.64 | $50.32 | $89.76 | +105.20% |
| April, 2025 | $68.33 | $62.71 | $74.94 | +116.93% |
| May, 2025 | $65.89 | $65.69 | $75.28 | +109.18% |
| June, 2025 | $61.30 | $59.70 | $70.50 | +94.60% |
| July, 2025 | $63.24 | $60.42 | $71.96 | +100.77% |
| August, 2025 | $55.52 | $53.52 | $68.35 | +76.25% |
| September, 2025 | $58.02 | $54.28 | $60.88 | +84.18% |
| October, 2025 | $59.64 | $57.19 | $64.21 | +89.35% |
| November, 2025 | $70.89 | $59.47 | $71.74 | +125.03% |
| December, 2025 | $72.11 | $66.03 | $80.60 | +128.92% |
Structure Therapeutics Inc Adr Stock (GPCR) Price Forecast for 2026
The predicted value for Structure Therapeutics Inc Adr (GPCR) in 2026 is set at an average of $92.85. Estimates vary from a peak of $119.77 to a trough of $65.94, indicating an +194.77% surge from the present price of $31.50.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $68.99 | $67.51 | $77.41 | +119.03% |
| February, 2026 | $69.27 | $65.94 | $72.58 | +119.91% |
| March, 2026 | $76.42 | $68.98 | $78.67 | +142.59% |
| April, 2026 | $112.26 | $74.93 | $114.78 | +256.37% |
| May, 2026 | $99.19 | $87.67 | $119.77 | +214.89% |
| June, 2026 | $108.63 | $95.87 | $113.14 | +244.84% |
| July, 2026 | $94.23 | $74.03 | $109.29 | +199.13% |
| August, 2026 | $93.54 | $88.85 | $95.64 | +196.95% |
| September, 2026 | $92.67 | $90.98 | $100.50 | +194.19% |
| October, 2026 | $95.63 | $85.75 | $98.17 | +203.57% |
| November, 2026 | $93.04 | $89.47 | $98.54 | +195.37% |
| December, 2026 | $73.39 | $69.72 | $95.56 | +132.99% |
Structure Therapeutics Inc Adr Stock (GPCR) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Structure Therapeutics Inc Adr (GPCR) is $107.49, with a high forecast of $142.15 and a low forecast of $72.84. This indicates an +241.25% increase from the last price of $31.50.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $77.03 | $72.84 | $77.58 | +144.55% |
| February, 2027 | $85.61 | $74.90 | $89.61 | +171.77% |
| March, 2027 | $85.43 | $84.72 | $90.11 | +171.21% |
| April, 2027 | $92.19 | $86.75 | $99.63 | +192.68% |
| May, 2027 | $87.69 | $85.98 | $97.29 | +178.38% |
| June, 2027 | $90.69 | $86.19 | $93.02 | +187.91% |
| July, 2027 | $119.75 | $90.77 | $129.63 | +280.14% |
| August, 2027 | $140.93 | $119.63 | $141.06 | +347.39% |
| September, 2027 | $124.82 | $110.38 | $142.15 | +296.26% |
| October, 2027 | $106.73 | $97.75 | $136.51 | +238.81% |
| November, 2027 | $113.91 | $106.86 | $123.37 | +261.61% |
| December, 2027 | $121.44 | $113.40 | $125.71 | +285.53% |
Structure Therapeutics Inc Adr Stock (GPCR) Price Forecast for 2028
In 2028, Structure Therapeutics Inc Adr (GPCR) is projected to reach an average price of $125.22, with a high projection of $164.52 and a low estimate of $85.92. This indicates an +297.53% rise from the last price of $31.50.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $114.51 | $113.07 | $123.52 | +263.51% |
| February, 2028 | $121.11 | $111.80 | $124.39 | +284.47% |
| March, 2028 | $120.81 | $116.35 | $125.26 | +283.51% |
| April, 2028 | $91.30 | $85.92 | $94.28 | +189.85% |
| May, 2028 | $96.54 | $90.28 | $97.64 | +206.48% |
| June, 2028 | $104.74 | $92.60 | $107.48 | +232.52% |
| July, 2028 | $117.05 | $103.44 | $118.03 | +271.60% |
| August, 2028 | $115.65 | $107.48 | $118.67 | +267.15% |
| September, 2028 | $111.16 | $106.02 | $117.16 | +252.88% |
| October, 2028 | $116.81 | $109.68 | $117.12 | +270.84% |
| November, 2028 | $155.02 | $116.02 | $156.60 | +392.13% |
| December, 2028 | $145.04 | $142.53 | $164.52 | +360.45% |
Structure Therapeutics Inc Adr Stock (GPCR) Price Forecast for 2029
The 2029 price forecast for Structure Therapeutics Inc Adr Stock (GPCR) is $131.01 on average, with a high prediction of $159.89 and a low estimate of $102.12. This represents an +315.89% increase from the previous price of $31.50.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $155.38 | $133.09 | $159.89 | +393.28% |
| February, 2029 | $138.54 | $121.46 | $156.38 | +339.82% |
| March, 2029 | $142.47 | $137.91 | $147.58 | +352.30% |
| April, 2029 | $142.03 | $141.83 | $150.93 | +350.90% |
| May, 2029 | $147.74 | $137.85 | $150.60 | +369.03% |
| June, 2029 | $143.89 | $143.23 | $151.98 | +356.81% |
| July, 2029 | $104.12 | $102.12 | $150.25 | +230.54% |
| August, 2029 | $110.17 | $103.88 | $110.98 | +249.76% |
| September, 2029 | $112.75 | $109.61 | $117.32 | +257.94% |
| October, 2029 | $124.67 | $113.08 | $127.03 | +295.76% |
| November, 2029 | $129.72 | $122.14 | $137.71 | +311.82% |
| December, 2029 | $128.61 | $127.13 | $137.03 | +308.29% |
Structure Therapeutics Inc Adr Stock (GPCR) Price Forecast for 2030
Structure Therapeutics Inc Adr Stock (GPCR) is expected to reach an average price of $152.61 in 2030, with a high forecast of $186.90 and a low forecast of $118.32. This signifies an +384.47% surge from the last price of $31.50.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $132.91 | $126.06 | $134.10 | +321.92% |
| February, 2030 | $157.29 | $131.60 | $172.38 | +399.35% |
| March, 2030 | $178.38 | $158.08 | $180.91 | +466.29% |
| April, 2030 | $167.32 | $155.80 | $186.90 | +431.18% |
| May, 2030 | $176.88 | $164.83 | $183.27 | +461.54% |
| June, 2030 | $166.86 | $145.17 | $171.79 | +429.72% |
| July, 2030 | $174.24 | $162.49 | $174.79 | +453.13% |
| August, 2030 | $169.81 | $167.22 | $176.14 | +439.10% |
| September, 2030 | $174.77 | $163.89 | $176.82 | +454.84% |
| October, 2030 | $175.53 | $170.12 | $178.69 | +457.23% |
| November, 2030 | $122.99 | $118.32 | $177.63 | +290.45% |
| December, 2030 | $128.64 | $122.94 | $129.03 | +308.38% |
0.42%
0.16%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):